Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
PITTSBURGH, June 10 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL )
announced today that it has signed a license and supply agreement with
NATCO Pharma Ltd. (NATCO) for NATCO's glatiramer acetate pre-filled
syringes, a generic version of Teva's Copaxone(R), which is used to treat
Oncology Drug Pemnat Launched By NATCO Natco
Pharma Ltd, based in Hyderabad, India, has announced the launch of a generic version of Pemetrexed a drug used to treat certain types of lung cancer. A very costly// preparation, Pemnat is priced at Rs 25,500 a vial. However the imported version of the same medication, costs a whopping Rs 79,...
Natco in Biological Technology
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
PHILADELPHIA, April 2 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District
Court for the Southern District of New York against Natco
("Natco") for infringement of two of Shire's patents: U.S. Patent No.
Shire begins the year with a strong performance
...harmaceuticals Inc. and Matrix Laboratories Inc.
(collectively "Mylan") and natco
Pharma Limited ("Natco") for infringement of
certain of Shire's FOSRENOL pa...d in response to
Abbreviated New Drug Applications filed by Barr, Mylan and natco
approval to market and sell generic versions of Shire's 500 mg,...